Melatonin

Byaibio

Melatonin is a small-molecule therapeutic agent with preclinical and emerging clinical evidence, and it is discussed here as a compound with mechanistic promise in ovarian aging and as a comparator for the novel nasal-administered analog mt a2. Its primary relevance is as a protective, pleiotropic agent that can modulate oxidative stress, inflammation, and mitochondrial biogenesis, with the Key Facts indicating evidence from preclinical and emerging clinical studies. In a monocrotaline-induced pulmonary arterial hypertension rat model, melatonin showed protective effects similar to sildenafil, supporting its role in pulmonary arterial hypertension (PMID:41679692). It is also used as a reference compound in drug-permeability optimization work, highlighting its utility in medicinal chemistry and membrane transport studies (PMID:41941324). Overall, the literature points to melatonin as a biologically active benchmark compound with applications spanning cardiovascular disease models and reproductive aging research (PMID:41833148).

Pulmonary arterial hypertension

  • In a rat model of monocrotaline-induced pulmonary arterial hypertension, melatonin produced protective effects comparable to sildenafil, with analysis focused on oxidative stress, inflammation, and mitochondrial biogenesis. (PMID:41679692)
  • The 2026 Molecular and Cellular Endocrinology study positioned melatonin as a comparator for assessing cardiopulmonary protection in experimental disease. (PMID:41679692)
  • The reported effects support a mechanistic role for melatonin in countering injury pathways relevant to pulmonary vascular remodeling. (PMID:41679692)

Ovarian aging and reproductive health

  • A 2026 Tissue & Cell review on aging and longevity highlighted melatonin as having mechanistic promise for ovarian aging and ovarian function/health. (PMID:41833148)
  • The summary describes melatonin as supported by preclinical and emerging clinical studies in this context, indicating translational interest beyond basic biology. (PMID:41833148)
  • Its relevance to reproductive aging is framed as part of broader longevity-related mechanisms rather than a single-target intervention. (PMID:41833148)

Drug development and permeability

  • Melatonin served as a reference compound in a 2026 Journal of Medicinal Chemistry study using an interpretable, thermodynamics-based deep learning framework for predicting and optimizing drug membrane permeability. (PMID:41941324)
  • In that context, melatonin was used as a benchmark against the designed analog mt a2, which was described as a novel nasal-administered melatonin analog. (PMID:41941324)
  • This use underscores melatonin’s value as a chemically and pharmacologically informative standard in permeability modeling and analog design. (PMID:41941324)